Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Third Harmonic Bio, Inc. - Common Stock (NQ: THRD )

11.50 -0.65 (-5.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Third Harmonic Bio, Inc. - Common Stock

< Previous 1 2 Next >
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
From Third Harmonic Bio
Via GlobeNewswire
Recap: Third Harmonic Bio Q4 Earnings
Via Benzinga
Third Harmonic Bio: Q3 Earnings Insights
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q1 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q4 2023
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Leadership Changes
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces First Quarter 2023 Financial Results
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases 
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases 
From Third Harmonic Bio
Via GlobeNewswire
Top 5 Health Care Stocks That May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Top 5 Health Care Stocks That May Surge
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 152 stocks made new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.